The best indicator for CSX Corporation (CSX)
We backtested 20 indicators across daily, weekly and hourly charts on real CSX Corporation (CSX) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
Stochastic
On the weekly chart, this is the strongest risk-adjusted edge we found for CSX Corporation (CSX) over ~45.8 years — trailing buy-and-hold by 6.5% CAGR.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | Stochastic ✓ | Weekly | 7.4% | 0.51 | -57.1% | 87.8% | 49 | -6.5% |
| 2 | WaveTrend (8/6/4) ✓ | Daily | 8.8% | 0.49 | -60.8% | 72.2% | 169 | -5.1% |
| 3 | Williams %R ✓ | Weekly | 7.2% | 0.47 | -66.8% | 82.0% | 61 | -6.7% |
| 4 | EMA 50/200 Cross ✓ | Daily | 8.0% | 0.45 | -44.2% | 42.4% | 33 | -5.9% |
| 5 | ADX / DMI ✓ | Weekly | 6.0% | 0.42 | -35.1% | 53.7% | 67 | -7.8% |
| 6 | SMA 50/200 Cross ✓ | Daily | 7.2% | 0.41 | -59.2% | 48.4% | 31 | -6.7% |
| 7 | EMA 20/50 Cross ✓ | Weekly | 6.9% | 0.41 | -48.2% | 54.2% | 24 | -6.9% |
| 8 | CCI ✓ | Daily | 6.1% | 0.4 | -52.6% | 71.4% | 213 | -7.8% |
| 9 | RSI Trend (>50) ✓ | Weekly | 6.3% | 0.39 | -48.6% | 51.9% | 133 | -7.6% |
| 10 | Donchian Breakout ✓ | Weekly | 5.8% | 0.38 | -58.1% | 52.4% | 42 | -8.1% |
| 11 | Money Flow Index ✓ | Daily | 5.0% | 0.37 | -65.7% | 82.5% | 40 | -8.8% |
| 12 | Donchian Midline ✓ | Weekly | 5.5% | 0.36 | -50.3% | 52.7% | 129 | -8.3% |
| 13 | Stochastic ✓ | Daily | 5.1% | 0.35 | -53.8% | 67.6% | 219 | -8.8% |
| 14 | Williams %R ✓ | Daily | 5.2% | 0.35 | -58.2% | 68.3% | 281 | -8.7% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For CSX Corporation (CSX), Stochastic on the weekly timeframe gave the best balance of return and risk in our test. It still trailed buy-and-hold on raw return — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.